This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1977 Jan 6;265(5589):81-2.

doi: 10.1038/265081a0.

Concanavalin A as a carrier of daunomycin

T Kitao, K Hattori

PMID: 834249
DOI: 10.1038/265081a0

Concanavalin A as a carrier of daunomycin

T Kitao et al. Nature. 1977.

. 1977 Jan 6;265(5589):81-2.

doi: 10.1038/265081a0.

Authors

T Kitao, K Hattori

PMID: 834249
DOI: 10.1038/265081a0

No abstract available

PubMed Disclaimer

Similar articles

Daunomycin pharmacological activity at the cellular level.
Di Marco A. Di Marco A. Pathol Biol. 1967 Oct;15(19):897-902. Pathol Biol. 1967. PMID: 4297686 No abstract available.
Comparison of the antileukemic effect in mice of adriamycin (NSC-123127) with daunomycin (NSC-82151).
Sandberg JS, Howsden FL, DiMarco A, Goldin A. Sandberg JS, et al. Cancer Chemother Rep. 1970 Feb;54(1):1-7. Cancer Chemother Rep. 1970. PMID: 5527012 No abstract available.
Cytological and cytochemical analysis of Ehrlich ascites tumor cells treated with daunomycin.
Bassleer R, Goessens G, Lepoint A, Desaive C, Kinet-Denoel C. Bassleer R, et al. Beitr Pathol. 1973 Dec;150(3):261-73. doi: 10.1016/s0005-8165(73)80056-3. Beitr Pathol. 1973. PMID: 4771313 No abstract available.
Enhancement of antitumor effectiveness of ICRF-159 (NSC-129943) against early L1210 leukemia by combination with cis-diamminedichloroplatinum (NSC-119875) or daunomycin (NSC-82151).
Woodman RJ. Woodman RJ. Cancer Chemother Rep 2. 1974 Mar;4(1):45-52. Cancer Chemother Rep 2. 1974. PMID: 4826499 No abstract available.
Daunomycin- and adriamycin-N-(2-hydroxypropyl)methacrylamide copolymer conjugates; toxicity reduction by improved drug-delivery.
Seymour LW, Duncan R, Kopecková P, Kopecek J. Seymour LW, et al. Cancer Treat Rev. 1987 Dec;14(3-4):319-27. doi: 10.1016/0305-7372(87)90024-7. Cancer Treat Rev. 1987. PMID: 3326668 Review. No abstract available.

See all similar articles

Cited by

Rosette formation of tumor cells with concanavalin A treated erythrocytes.
Kitao T, Hattori K. Kitao T, et al. Experientia. 1980 Mar 15;36(3):342-3. doi: 10.1007/BF01952315. Experientia. 1980. PMID: 7189473
Interaction of peanut agglutinin with normal human lymphocytes and with leukemic cells.
Reisner Y, Biniaminov M, Rosenthal E, Sharon N, Ramot B. Reisner Y, et al. Proc Natl Acad Sci U S A. 1979 Jan;76(1):447-51. doi: 10.1073/pnas.76.1.447. Proc Natl Acad Sci U S A. 1979. PMID: 311473 Free PMC article.
A covalent linkage between daunorubicin and proteins that is stable in serum and reversible by lysosomal hydrolases, as required for a lysosomotropic drug-carrier conjugate: in vitro and in vivo studies.
Trouet A, Masquelier M, Baurain R, Deprez-De Campeneere D. Trouet A, et al. Proc Natl Acad Sci U S A. 1982 Jan;79(2):626-9. doi: 10.1073/pnas.79.2.626. Proc Natl Acad Sci U S A. 1982. PMID: 6952214 Free PMC article.
Lectins as the prominent potential to deliver bioactive metal nanoparticles by recognizing cell surface glycans.
Bala Subramaniyan S, Veerappan A. Bala Subramaniyan S, et al. Heliyon. 2024 Apr 11;10(8):e29394. doi: 10.1016/j.heliyon.2024.e29394. eCollection 2024 Apr 30. Heliyon. 2024. PMID: 38638961 Free PMC article. Review.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- The Lens - Patent Citations Database